Limited variation in BK virus T-cell epitopes revealed by next-generation sequencing

Journal of Clinical Microbiology

Volumn 53, Issue 10, 2015, Pages 3226-3233

  Sahoo, Malaya K ^a   Tan, Susanna K ^a   Chen, Sharon F ^a   Kapusinszky, Beatrix ^a   Concepcion, Katherine R ^a   Kjelson, Lynn ^b   Mallempati, Kalyan ^a   Farina, Heidi M ^a   Fernández Viña, Marcelo ^a   Tyan, Dolly ^a   Grimm, Paul C ^a   W Anderson, Matthew ^a   Concepcion, Waldo ^a   Pinskya, Benjamin A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPITOPE; HLA A2 ANTIGEN; HLA B ANTIGEN; HLA B702 ANTIGEN; HLA B8 ANTIGEN; UNCLASSIFIED DRUG; VIRUS DNA;

ACCURACY; ARTICLE; BIOINFORMATICS; BK VIRUS; CONTROLLED STUDY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ALGORITHM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; MOLECULAR DYNAMICS; NEXT GENERATION SEQUENCING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; QUANTITATIVE ANALYSIS; VIRUS GENE; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS STRAIN; ADOLESCENT; CHEMISTRY; CHILD; CONSERVED SEQUENCE; DNA SEQUENCE; FEMALE; GENETIC VARIATION; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; BK VIRUS; CHILD; CHILD, PRESCHOOL; CONSERVED SEQUENCE; DNA, VIRAL; EPITOPES, T-LYMPHOCYTE; FEMALE; GENETIC VARIATION; GENOME, VIRAL; HUMANS; MALE; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84941978840     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01385-15     Document Type: Article

References (39)

1. Balba GP, Javaid B, Timpone JG, Jr. 2013. BK polyomavirus infection in the renal transplant recipient. Infect Dis Clin NorthAm27:271-283. http: //dx. doi. org/10. 1016/j. idc. 2013. 02. 002.
2. Funk GA, Gosert R, Comoli P, Ginevri F, Hirsch HH. 2008. Polyomavirus BK replication dynamics in vivo and in silico to predict cytopathology and viral clearance in kidney transplants. Am J Transplant 8:2368-2377. http://dx. doi. org/10. 1111/j. 1600-6143. 2008. 02402. x.
3. Hirsch HH. 2005. BK virus: opportunity makes a pathogen. Clin Infect Dis 41:354-360. http://dx. doi. org/10. 1086/431488.
4. Knowles WA, Pipkin P, Andrews N, Vyse A, Minor P, Brown DW, Miller E. 2003. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 71:115-123. http://dx. doi. org/10. 1002/jmv. 10450.
5. Ginevri F, Azzi A, Hirsch HH, Basso S, Fontana I, Cioni M, Bodaghi S, Salotti V, Rinieri A, Botti G, Perfumo F, Locatelli F, Comoli P. 2007. Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant 7:2727-2735. http://dx. doi. org/10. 1111/j. 1600-6143. 2007. 01984. x.
6. Hirsch HH, Randhawa P. 2013. BK polyomavirus in solid organ transplantation. Am J Transplant 13(Suppl 4):179-188. http://dx. doi. org/10 . 1111/ajt. 12110.
7. Binggeli S, Egli A, Schaub S, Binet I, Mayr M, Steiger J, Hirsch HH. 2007. Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients. Am J Transplant 7:1131-1139. http://dx. doi. org/10. 1111/j. 1600-6143. 2007. 01754. x.
8. Schachtner T, Muller K, Stein M, Diezemann C, Sefrin A, Babel N, Reinke P. 2011. BK virus-specific immunity kinetics: a predictor of recovery from polyomavirus BK-associated nephropathy. Am J Transplant 11: 2443-2452. http://dx. doi. org/10. 1111/j. 1600-6143. 2011. 03693. x.
9. Schmidt T, Adam C, Hirsch HH, Janssen MW, Wolf M, Dirks J, Kardas P, Ahlenstiel-Grunow T, Pape L, Rohrer T, Fliser D, Sester M, Sester U. 2014. BK polyomavirus-specific cellular immune responses are agedependent and strongly correlate with phases of virus replication. Am J Transplant 14:1334-1345. http://dx. doi. org/10. 1111/ajt. 12689.
10. Heslop HE, Slobod KS, Pule MA, Hale GA, Rousseau A, Smith CA, Bollard CM, Liu H, Wu MF, Rochester RJ, Amrolia PJ, Hurwitz JL, Brenner MK, Rooney CM. 2010. Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood 115:925-935. http://dx. doi. org/10 . 1182/blood-2009-08-239186.
11. Micklethwaite KP, Clancy L, Sandher U, Hansen AM, Blyth E, Antonenas V, Sartor MM, Bradstock KF, Gottlieb DJ. 2008. Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation. Blood 112:3974-3981. http://dx. doi. org/10 . 1182/blood-2008-06-161695.
12. Gerdemann U, Katari UL, Papadopoulou A, Keirnan JM, Craddock JA, Liu H, Martinez CA, Kennedy-Nasser A, Leung KS, Gottschalk SM, Krance RA, Brenner MK, Rooney CM, Heslop HE, Leen AM. 2013. Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant. Mol Ther 21:2113-2121. http://dx. doi . org/10. 1038/mt. 2013. 151.
13. Mueller K, Schachtner T, Sattler A, Meier S, Friedrich P, Trydzenskaya H, Hinrichs C, Trappe R, Thiel A, Reinke P, Babel N. 2011. BK-VP3 as a new target of cellular immunity in BK virus infection. Transplantation 91:100-107. http://dx. doi. org/10. 1097/TP. 0b013e3181fe1335.
14. Kapusinszky B, Chen SF, Sahoo MK, Lefterova MI, Kjelson L, Grimm PC, Kambham N, Concepcion W, Pinsky BA. 2013. BK polyomavirus subtype III in a pediatric renal transplant patient with nephropathy. J Clin Microbiol 51:4255-4258. http://dx. doi. org/10. 1128/JCM. 01801-13.
15. Li H, Durbin R. 2010. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26:589-595. http://dx. doi. org /10. 1093/bioinformatics/btp698.
16. Milne I, Stephen G, Bayer M, Cock PJ, Pritchard L, Cardle L, Shaw PD, Marshall D. 2013. Using Tablet for visual exploration of secondgeneration sequencing data. Brief Bioinform 14:193-202. http://dx. doi . org/10. 1093/bib/bbs012.
17. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R, 1000 Genome Project Data Processing Subgroup. 2009. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25:2078-2079. http://dx. doi. org/10. 1093/bioinformatics /btp352.
18. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG. 2007. Clustal W and Clustal X version 2. 0. Bioinformatics 23:2947-2948. http://dx. doi. org/10. 1093/bioinformatics /btm404.
19. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28:2731-2739. http://dx. doi. org/10. 1093/molbev/msr121.
20. Sahoo MK, Lefterova MI, Yamamoto F, Waggoner JJ, Chou S, Holmes SP, Anderson MW, Pinsky BA. 2013. Detection of cytomegalovirus drug resistance mutations by next-generation sequencing. J Clin Microbiol 51: 3700-3710. http://dx. doi. org/10. 1128/JCM. 01605-13.
21. Flaherty P, Natsoulis G, Muralidharan O, Winters M, Buenrostro J, Bell J, Brown S, Holodniy M, Zhang N, Ji HP. 2012. Ultrasensitive detection of rare mutations using next-generation targeted resequencing. Nucleic Acids Res 40:e2. http://dx. doi. org/10. 1093/nar/gkr861.
22. McCullagh P, Nelder JA. 1989. Generalized linear models, 2nd ed. Chapman and Hall, London, United Kingdom.
23. Wang C, Mitsuya Y, Gharizadeh B, Ronaghi M, Shafer RW. 2007. Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance. Genome Res 17:1195-1201. http://dx . doi. org/10. 1101/gr. 6468307.
24. Mani J, Jin N, Schmitt M. 2014. Cellular immunotherapy for patients with reactivation of JC and BK polyomaviruses after transplantation. Cytotherapy, in press. http://dx. doi. org/10. 1016/j. jcyt. 2014. 04. 003.
25. Li J, Melenhorst J, Hensel N, Rezvani K, Sconocchia G, Kilical Y, Hou J, Curfman B, Major E, Barrett AJ. 2006. T-cell responses to peptide fragments of the BK virus T antigen: implications for cross-reactivity of immune response to JC virus. J Gen Virol 87:2951-2960. http://dx. doi. org /10. 1099/vir. 0. 82094-0.
26. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389-3402. http: //dx. doi. org/10. 1093/nar/25. 17. 3389.
27. Carr MJ, McCormack GP, Mutton KJ, Crowley B. 2006. Unique BK virus non-coding control region (NCCR) variants in hematopoietic stem cell transplant recipients with and without hemorrhagic cystitis. J Med Virol 78:485-493. http://dx. doi. org/10. 1002/jmv. 20566.
28. Boldorini R, Allegrini S, Miglio U, Paganotti A, Veggiani C, Mischitelli M, Monga G, Pietropaolo V. 2009. Genomic mutations of viral protein 1 and BK virus nephropathy in kidney transplant recipients. J Med Virol 81:1385-1393. http://dx. doi. org/10. 1002/jmv. 21520.
29. Tremolada S, Delbue S, Castagnoli L, Allegrini S, Miglio U, Boldorini R, Elia F, Gordon J, Ferrante P. 2010. Mutations in the external loops of BK virus VP1 and urine viral load in renal transplant recipients. J Cell Physiol 222:195-199. http://dx. doi. org/10. 1002/jcp. 21937.
30. Krautkrämer E, Klein TM, Sommerer C, Schnitzler P, Zeier M. 2009. Mutations in the BC-loop of the BKV VP1 region do not influence viral load in renal transplant patients. J Med Virol 81:75-81. http://dx. doi. org /10. 1002/jmv. 21359.
31. Olsen GH, Hirsch HH, Rinaldo CH. 2009. Functional analysis of polyomavirus BK non-coding control region quasispecies from kidney transplant recipients. J Med Virol 81:1959-1967. http://dx. doi. org/10. 1002 /jmv. 21605.
32. Luo C, Bueno M, Kant J, Martinson J, Randhawa P. 2009. Genotyping schemes for polyomavirus BK, using gene-specific phylogenetic trees and single nucleotide polymorphism analysis. J Virol 83:2285-2297. http://dx . doi. org/10. 1128/JVI. 02180-08.
33. Chehadeh W, Nampoory MR. 2013. Genotypic diversity of polyomaviruses circulating among kidney transplant recipients in Kuwait. J Med Virol 85:1624-1631. http://dx. doi. org/10. 1002/jmv. 23639.
34. Drew RJ, Walsh A, Laoi BN, Crowley B. 2012. Phylogenetic analysis of the complete genome of 11 BKV isolates obtained from allogenic stem cell transplant recipients in Ireland. J Med Virol 84:1037-1048. http://dx. doi . org/10. 1002/jmv. 23240.
35. Grad YH, Newman R, Zody M, Yang X, Murphy R, Qu J, Malboeuf CM, Levin JZ, Lipsitch M, DeVincenzo J. 2014. Within-host wholegenome deep sequencing and diversity analysis of human respiratory syncytial virus infection reveals dynamics of genomic diversity in the absence and presence of immune pressure. J Virol 88:7286-7293. http://dx. doi. org /10. 1128/JVI. 00038-14.
36. Ni YH, Chang MH, Chen PJ, Hsu HY, Lu TW, Lin KH, Lin DT. 1999. Decreased diversity of hepatitis C virus quasispecies during bone marrow transplantation.J Med Virol 58:132-138.http://dx.doi.org/10.1002/(SICI)1096-9071(199906)58:2132::AID-JMV6-3.0.CO;2-V.
37. Renzette N, Gibson L, Jensen JD, Kowalik TF. 2014. Human cytomegalovirus intrahost evolution-a new avenue for understanding and controlling herpesvirus infections. Curr Opin Virol 8:109-115.http://dx.doi.org/10.1016/j.coviro.2014.08.001.
38. Van den Hoecke S, Verhelst J, Vuylsteke M, Saelens X. 2015. Analysis of the genetic diversity of influenza A viruses using next-generation DNA sequencing. BMC Genomics 16:79. http://dx. doi. org/10. 1186/s12864-015-1284-z.
39. Loman NJ, Misra RV, Dallman TJ, Constantinidou C, Gharbia SE, Wain J, Pallen MJ. 2012. Performance comparison of benchtop highthroughput sequencing platforms. Nat Biotechnol 30:434-439. http://dx . doi. org/10. 1038/nbt. 2198.